Community pharmacy and cash reward: a winning combination for chlamydia screening?
- Marian J Currie1,
- Louise S Deeks1,2,
- Gabrielle M Cooper2,
- Sarah J Martin1,3,
- Rhian M Parker4,
- Rendry Del Rosario3,
- Jane S Hocking5,
- Francis J Bowden1,3
- 1Academic Unit of Internal Medicine, The Australian National University Medical School, Canberra Hospital, Canberra, Australia
- 2Discipline of Pharmacy, Faculty of Health, University of Canberra, Canberra, Australia
- 3Canberra Sexual Health Centre, Canberra Hospital, Canberra, Australia
- 4Australian Primary Health Care Research Institute, The Australian National University, Canberra, Australia
- 5Centre for Women's Health, Gender and Society, Melbourne School of Population Health, University of Melbourne, Melbourne, Australia
- Correspondence to Dr Marian J Currie, Research Program Manager, Academic Unit of Internal Medicine, ANU Medical School, Building 4, Level 2, Canberra Hospital, PO Box 11, Woden, ACT 2606, Australia;
- Accepted 24 September 2012
- Published Online First 23 October 2012
Objectives To date, the uptake of chlamydia screening in community pharmacies has been limited. The objective of this cross-sectional study was to determine if a cash reward, offered to both the provider and the consumer of chlamydia screening, increased the uptake of screening in community pharmacies.
Methods During 4 weeks in 2011, chlamydia screening and education were offered in four city and two suburban pharmacies to people aged 16–30 years. Those who provided a urine sample for testing, contact details, and completed a brief questionnaire were rewarded with $A10. Positive participants, and their nominated contacts, were offered treatment.
Results Over a period of 751.5 h, 979 testing kits were requested, and 900 (93%) urine samples returned. Using probabilistic linkage methods, we determined that 671/900 (75%) urine samples were from unique individuals. 0.9 unique samples were obtained/hour of screening, 63% of which were provided by men. 19/671 (2.8%; 95% CI 1.7% to 4.4%) people tested positive, 5.2% (95% CI 2.8% to 8.8%) of women, and 1.4% (1.4 0.5 to 3.1) of men. 11/19 (58%) people were contacted and treated—two for suspected pelvic inflammatory disease.
Conclusions Providing a cash reward to encourage chlamydia screening in community pharmacies resulted in greater participation rates than previously reported pharmacy-based studies, particularly among men. Easily implemented mechanisms to reduce inappropriate repeat screening, incorrect contact details and effects on pharmacy work flow may enhance the efficiency of this approach.